$UNVC is about to launch into uncharted territory.

$UNVC is about to launch into uncharted territory. Can you even imagine a tiny non-reporting company trading at just .0029 per share is about to take the entire world by storm? Sound too good to possible be true? Well, just wait and see. This tiny little gem is about to reveal a cannabis transdermal patch that will be used to treat opioid addiction, Parkinson disease, multiple sclerosis, diabetes, and even cancer. If you think such a remarkable product is just not possible, then perhaps you just might believe it if you were told Merck and Pfizer would be selling their product for them. That is right, two of the largest big pharma companies in the entire world are pounding on $UNVC doors and are eager to sell their patch for them. Yet, that is not all. We just learned that insurance will cover this patch and that it will be offered free to opioid addicts --- can you say government contracts? Who else could offer the product for free to the addicted? This is a low float gem with the CEO said to own around 200 million of the only 1.2 billion authorized and he said he has not sold a single share. Not only that, but the CEO Doctor David Dalton partnered with a company called AGRiMED to develop this patch, and it is likely the founders and managers of that company also were given hundreds of millions of shares. This means the float is locked or darn close to it. Check if out folks. A life changer and record breaker is coming to life right before your very eyes. Millionaires will be minted, and you can bank on that.